Literature DB >> 1796760

Expression of the osteonectin gene potentially controlled by multiple cis- and trans-acting factors in cultured bone cells.

P Dominguez1, K Ibaraki, P G Robey, T E Hefferan, J D Termine, M F Young.   

Abstract

The cis-acting regulatory elements of the osteonectin gene have been studied using a chloramphenicol acetyltransferase (CAT) promoter assay in osteonectin-expressing and nonexpressing cultured cells. When various stretches of the promoter were transiently transfected into fetal bovine bone cells, a positive element was detected in the DNA located between bases -504 and 11 (1 being the start of transcription) and a negative element between bases -900 and -504. The positive element of the promoter also conferred preferential expression of the gene, showing more activity in cells with higher levels of osteonectin mRNA expression. A 1.2 kb fragment of intron 1 displayed a negative effect on CAT expression when inserted 5' to the promoter. An additional regulatory element was found in DNA encoding exon 1, which significantly influenced expression of the gene in fetal bovine bone cells. Gel shift analysis using positive genomic elements located 5' to the start of transcription indicated that one of the nuclear proteins that interacts with the osteonectin promoter may be related to the transcription factor AP2.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1796760     DOI: 10.1002/jbmr.5650061015

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  8 in total

1.  miR-29 suppression of osteonectin in osteoblasts: regulation during differentiation and by canonical Wnt signaling.

Authors:  Kristina Kapinas; Catherine B Kessler; Anne M Delany
Journal:  J Cell Biochem       Date:  2009-09-01       Impact factor: 4.429

2.  On the role of AP2 in epithelial-specific gene expression.

Authors:  T Magnaldo; R G Vidal; M Ohtsuki; I M Freedberg; M Blumenberg
Journal:  Gene Expr       Date:  1993

3.  Identification of an intronic enhancer that nullifies upstream repression of SPARC gene expression.

Authors:  K Satyamoorthy; S J Samulewicz; L D Thornburg; A Basu; C C Howe
Journal:  Nucleic Acids Res       Date:  1997-08-01       Impact factor: 16.971

4.  A single nucleotide polymorphism in osteonectin 3' untranslated region regulates bone volume and is targeted by miR-433.

Authors:  Neha S Dole; Kristina Kapinas; Catherine B Kessler; Siu-Pok Yee; Douglas J Adams; Renata C Pereira; Anne M Delany
Journal:  J Bone Miner Res       Date:  2015-04       Impact factor: 6.741

5.  A new reporter vector system based on flow-cytometry to detect promoter activity.

Authors:  Sundo Jung; Ji-Hye Choi; Changwan Hong; Hyunji Lee; Yoon-Kyung Park; Jung Hoon Shin; Jae-Won Park; Se-Ho Park
Journal:  Immune Netw       Date:  2009-12-31       Impact factor: 6.303

6.  Gap junctional communication modulates gene expression in osteoblastic cells.

Authors:  F Lecanda; D A Towler; K Ziambaras; S L Cheng; M Koval; T H Steinberg; R Civitelli
Journal:  Mol Biol Cell       Date:  1998-08       Impact factor: 4.138

7.  Osteonectin/SPARC polymorphisms in Caucasian men with idiopathic osteoporosis.

Authors:  A M Delany; D J McMahon; J S Powell; D A Greenberg; E S Kurland
Journal:  Osteoporos Int       Date:  2007-12-15       Impact factor: 4.507

8.  Tumor associated stromal cells play a critical role on the outcome of the oncolytic efficacy of conditionally replicative adenoviruses.

Authors:  M Verónica Lopez; Diego L Viale; Eduardo G A Cafferata; Alicia I Bravo; Cecilia Carbone; David Gould; Yuti Chernajovsky; Osvaldo L Podhajcer
Journal:  PLoS One       Date:  2008-04-08       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.